Celularity Inc. CELU
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 41.24% | -6.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 41.24% | -6.29% | |||
| Cost of Revenue | 61.64% | -80.31% | |||
| Gross Profit | 28.86% | 173.21% | |||
| SG&A Expenses | -46.10% | -39.16% | |||
| Depreciation & Amortization | -3.80% | 124.81% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -30.83% | -42.48% | |||
| Operating Income | 58.19% | 49.83% | |||
| Income Before Tax | -19.22% | 103.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -19.22% | 103.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.22% | 103.59% | |||
| EBIT | 58.19% | 49.83% | |||
| EBITDA | 68.39% | 54.72% | |||
| EPS Basic | -19.83% | 102.70% | |||
| Normalized Basic EPS | -16.07% | 105.30% | |||
| EPS Diluted | -7.00% | 102.33% | |||
| Normalized Diluted EPS | -12.56% | 105.09% | |||
| Average Basic Shares Outstanding | 0.95% | 2.16% | |||
| Average Diluted Shares Outstanding | -3.15% | 6.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||